Moody Aldrich Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-47,035	Closed	-$2.28M	–	154
2020 Q2	$2.28M	Sell	47,035 -73,181	-61%	-$3.51M	0.48%	78
2020 Q1	$5.08M	Sell	120,216 -170	-0.1%	-$7K	1.53%	18
2019 Q4	$5.15M	Buy	120,386 +23,147	+24%	+$1.01M	1.06%	29
2019 Q3	$3.5M	Buy	97,239 +63,493	+188%	+$1.93M	0.93%	45
2019 Q2	$902K	Sell	33,746 -26,263	-44%	-$671K	0.23%	90
2019 Q1	$1.61M	Sell	60,009 -38,797	-39%	-$906K	0.45%	84
2018 Q4	$1.6M	Buy	98,806 +5,921	+6%	+$115K	0.52%	73
2018 Q3	$1.93M	Buy	+92,885	New	+$1.46M	0.56%	79
2018 Q1	–	Sell	-35,701	Closed	-$1.07M	–	87
2017 Q4	$1.07M	Buy	35,701 +6,782	+23%	+$217K	0.87%	56
2017 Q3	$1.09M	Buy	28,919 +10,304	+55%	+$335K	1.12%	42
2017 Q2	$519K	Buy	+18,615	New	+$555K	0.65%	75
2016 Q4	–	Sell	-19,110	Closed	-$608K	–	89
2016 Q3	$608K	Buy	+19,110	New	+$648K	0.42%	90